Two Newly Isolated Enterobacter-Specific Bacteriophages: Biological Properties and Stability Studies

In an era of antibiotic therapy crisis caused by spreading antimicrobial resistance, and when recurrent urinary tract infections constitute a serious social and medical problem, the isolation and complex characterization of phages with a potential therapeutic application represents a promising solution. It is an inevitable, and even a necessary direction in the development of current phage research. In this paper, we present two newly isolated myoviruses that show lytic activity against multidrug-resistant clinical isolates of Enterobacter spp. (E. cloacae, E. hormaechei, and E. kobei), the genomes of which belong to a poorly represented phage group. Both phages were classified as part of the Tevenvirinae subfamily (Entb_43 was recognized as Karamvirus and Entb_45 as Kanagawavirus). Phage lytic spectra ranging from 40 to 60% were obtained. The most effective phage-to-bacteria ratios (MOI = 0.01 and MOI = 0.001) for both the phage amplification and their lytic activity against planktonic bacteria were also estimated. Complete adsorption to host cells were obtained after about 20 min for Entb_43 and 10 min for Entb_45. The phage lysates retained their initial titers even during six months of storage at both −70 °C and 4 °C, whereas storage at 37 °C caused a complete loss in their activity. We showed that phages retained their activity after incubation with solutions of silver and copper nanoparticles, which may indicate possible synergistic antibacterial activity. Moreover, a significant reduction in phage titers was observed after incubation with a disinfectant containing octenidinum dihydrochloridum and phenoxyethanol, as well as with 70% ethanol. The observed maintenance of phage activity during incubation in a urine sample, along with other described properties, may suggest a therapeutic potential of phages at the infection site after intravesical administration.

[1]  S. Brisse,et al.  In Vitro and In Vivo Assessments of Two Newly Isolated Bacteriophages against an ST13 Urinary Tract Infection Klebsiella pneumoniae , 2022, Viruses.

[2]  Ionela-Larisa Miftode,et al.  What Doesn’t Kill Them Makes Them Stronger: The Impact of the Resistance Patterns of Urinary Enterobacterales Isolates in Patients from a Tertiary Hospital in Eastern Europe , 2022, Antibiotics.

[3]  D. Van Tyne,et al.  Isolation and Characterization of Lytic Bacteriophages Targeting Diverse Enterobacter spp. Clinical Isolates , 2022, PHAGE.

[4]  Robin Patel,et al.  Considerations for the Use of Phage Therapy in Clinical Practice , 2022, Antimicrobial agents and chemotherapy.

[5]  Lijuan Yuan,et al.  Comparision of biological and genomic characteristics of five virulent bacteriophages against Enterobacter hormaechei. , 2021, Microbial pathogenesis.

[6]  Michaela Corina Crisan,et al.  Copper Nanoparticles: Synthesis and Characterization, Physiology, Toxicity and Antimicrobial Applications , 2021, Applied Sciences.

[7]  A. Nair,et al.  Characterization of a novel, biofilm dispersing, lytic bacteriophage against drug‐resistant Enterobacter cloacae , 2021, Journal of applied microbiology.

[8]  Evelien M. Adriaenssens,et al.  Phage Annotation Guide: Guidelines for Assembly and High-Quality Annotation , 2021, PHAGE.

[9]  S. Brenner,et al.  Nanotechnology Fundamentals Applied to Clinical Infectious Diseases and Public Health , 2021, Open forum infectious diseases.

[10]  Michał Wójcicki,et al.  Characterization and Genome Study of Novel Lytic Bacteriophages against Prevailing Saprophytic Bacterial Microflora of Minimally Processed Plant-Based Food Products , 2021, International journal of molecular sciences.

[11]  F. Stellacci,et al.  Broad-spectrum nanoparticles against bacteriophage infections , 2021, Nanoscale.

[12]  K. Hulten,et al.  Risk factors for microbiologic failure in children with Enterobacter species bacteremia , 2021, PloS one.

[13]  A. Maresso,et al.  Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection , 2021, Viruses.

[14]  S. S. Giri,et al.  The Characterization of a Novel Phage, pPa_SNUABM_DT01, Infecting Pseudomonas aeruginosa , 2021, Microorganisms.

[15]  Charles E. Grant,et al.  XSTREME: Comprehensive motif analysis of biological sequence datasets , 2021, bioRxiv.

[16]  S. Kakou-ngazoa,et al.  Investigation of Phages Infecting Escherichia coli Strains B and C, and Enterobacter cloacae in Sewage and Ebrié Lagoon, Côte d'Ivoire. , 2021, PHAGE.

[17]  Ying Zhang,et al.  Molecular Mechanisms and Epidemiology of Carbapenem-Resistant Enterobacter cloacae Complex Isolated from Chinese Patients During 2004–2018 , 2021, Infection and drug resistance.

[18]  K. Peck,et al.  Difference in the Clinical Outcome of Bloodstream Infections Caused by Klebsiella aerogenes and Enterobacter cloacae Complex , 2021, Open forum infectious diseases.

[19]  M. Castanheira,et al.  Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection , 2021, JAC-antimicrobial resistance.

[20]  N. Tikunova,et al.  A New Enterobacter cloacae Bacteriophage EC151 Encodes the Deazaguanine DNA Modification Pathway and Represents a New Genus within the Siphoviridae Family , 2021, Viruses.

[21]  Abdallah S. Abdelsattar,et al.  The Synergistic Effect of Biosynthesized Silver Nanoparticles and Phage ZCSE2 as a Novel Approach to Combat Multidrug-Resistant Salmonella enterica , 2021, Antibiotics.

[22]  S. Rutjes,et al.  Surface chemistry-dependent antiviral activity of silver nanoparticles , 2021, Nanotechnology.

[23]  J. Rodríguez-Baño,et al.  Clinical characteristics and outcome of bacteremia caused by Enterobacter cloacae and Klebsiella aerogenes: more similarities than differences. , 2021, Journal of global antimicrobial resistance.

[24]  S. Réhman,et al.  Characterization of a lytic EBP bacteriophage with large size genome against Enterobacter cloacae , 2021, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[25]  M. Vaneechoutte,et al.  Evaluation of the Stability of Bacteriophages in Different Solutions Suitable for the Production of Magistral Preparations in Belgium , 2021, Viruses.

[26]  A. Shariati,et al.  Bacteriophage therapy for inhibition of multi drug‐resistant uropathogenic bacteria: a narrative review , 2021, Annals of clinical microbiology and antimicrobials.

[27]  Martha R. J. Clokie,et al.  Preclinical data and safety assessment of phage therapy in humans , 2021, Current opinion in biotechnology.

[28]  V. Voliani,et al.  Antimicrobial Nano-Agents: The Copper Age , 2021, ACS nano.

[29]  Evelien M. Adriaenssens,et al.  A Roadmap for Genome-Based Phage Taxonomy , 2021, Viruses.

[30]  Brahma N. Singh,et al.  Chrysophanol-Functionalized Silver Nanoparticles for Anti-Adhesive and Anti-Biofouling Coatings to Prevent Urinary Catheter-Associated Infections , 2021 .

[31]  G. Węgrzyn,et al.  Phage–Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against Enterococcus faecalis , 2021, Viruses.

[32]  Qin Hu,et al.  Isolation and genomic characterization of P.A-5, a novel virulent bacteriophage against Enterobacter hormaechei. , 2021, Microbial pathogenesis.

[33]  Junxing Yang,et al.  Enterobacter cloacae infection of the shoulder in a 52-year-old woman without apparent predisposing risk factor: a case report and literature review , 2021, BMC Infectious Diseases.

[34]  Narmada Thanki,et al.  RefSeq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation , 2020, Nucleic Acids Res..

[35]  Ying Zhang,et al.  Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin , 2020, BMC Microbiology.

[36]  J. Borysowski,et al.  Phage Therapy: Towards a Successful Clinical Trial , 2020, Antibiotics.

[37]  N. Ács,et al.  Bacteriophage Enumeration and Detection Methods , 2020, Frontiers in Microbiology.

[38]  F. Vandenesch,et al.  Enterobacter cloacae colonisation and infection in a neonatal intensive care unit: retrospective investigation of preventive measures implemented after a multiclonal outbreak , 2020, BMC Infectious Diseases.

[39]  T. Kessler,et al.  Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial. , 2020, The Lancet. Infectious diseases.

[40]  T. G. Villa,et al.  Bacteriophages and Lysins as Possible Alternatives to Treat Antibiotic-Resistant Urinary Tract Infections , 2020, Antibiotics.

[41]  A. Okoh,et al.  Enterobacter cloacae harbouring blaNDM-1, blaKPC , and blaOXA-48-like carbapenem-resistant genes isolated from different environmental sources in South Africa , 2020 .

[42]  Xiaoyu Li,et al.  Genome sequence analysis of a novel Enterobacter cloacae phage, Ec_L1, belonging to the genus Eclunavirus , 2020, Archives of Virology.

[43]  G. Sutton,et al.  Newly Named Klebsiella aerogenes (formerly Enterobacter aerogenes) Is Associated with Poor Clinical Outcomes Relative to Other Enterobacter Species in Patients with Bloodstream Infection , 2020, Journal of Clinical Microbiology.

[44]  Jessica Pourraz,et al.  Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures , 2020, Palgrave Communications.

[45]  H. Wei,et al.  Application of Adaptive Evolution to Improve the Stability of Bacteriophages during Storage , 2020, Viruses.

[46]  D. A. Court,et al.  Characterization of the Enterobacter Phage vB_EclM_CIP9 , 2020, Microbiology Resource Announcements.

[47]  G. Węgrzyn,et al.  Characterization of a bacteriophage, vB_Eco4M-7, that effectively infects many Escherichia coli O157 strains , 2020, Scientific Reports.

[48]  Chao-Min Cheng,et al.  Role of pH Value in Clinically Relevant Diagnosis , 2020, Diagnostics.

[49]  Lu Sun,et al.  NCBI Taxonomy: a comprehensive update on curation, resources and tools , 2020, Database J. Biol. Databases Curation.

[50]  F. Tay,et al.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections , 2019, Advanced science.

[51]  Geoffrey L. Winsor,et al.  CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database , 2019, Nucleic Acids Res..

[52]  V. Mlambo,et al.  Characterization of Lytic Bacteriophages Infecting Multidrug-Resistant Shiga Toxigenic Atypical Escherichia coli O177 Strains Isolated From Cattle Feces , 2019, Front. Public Health.

[53]  A. Maresso,et al.  Constructing and Characterizing Bacteriophage Libraries for Phage Therapy of Human Infections , 2019, Front. Microbiol..

[54]  B. Verhasselt,et al.  A recurrent and transesophageal echocardiography–associated outbreak of extended-spectrum β-lactamase–producing Enterobacter cloacae complex in cardiac surgery patients , 2019, Antimicrobial Resistance & Infection Control.

[55]  Shikha Malik,et al.  Managing urinary tract infections through phage therapy: a novel approach , 2019, Folia Microbiologica.

[56]  O. Bajolet,et al.  Treatment of bone and joint infections caused by Enterobacter cloacae with a fluoroquinolone-cotrimoxazole combination. , 2019, International journal of antimicrobial agents.

[57]  M. Blanco,et al.  Biofilm formation by multidrug resistant Enterobacteriaceae strains isolated from solid organ transplant recipients , 2019, Scientific Reports.

[58]  P. Rossmanith,et al.  Don’t Shut the Stable Door after the Phage Has Bolted—The Importance of Bacteriophage Inactivation in Food Environments , 2019, Viruses.

[59]  T. Maerken,et al.  Nosocomial outbreak of extended-spectrum β-lactamase-producing Enterobacter cloacae among cardiothoracic surgical patients: causes and consequences. , 2019, The Journal of hospital infection.

[60]  K. Pardesi,et al.  Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review , 2019, Front. Microbiol..

[61]  C. Lundborg,et al.  Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species , 2019, Front. Microbiol..

[62]  Jing Yuan,et al.  Characterizing the Biology of Lytic Bacteriophage vB_EaeM_φEap-3 Infecting Multidrug-Resistant Enterobacter aerogenes , 2019, Front. Microbiol..

[63]  P. Hyman Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth , 2019, Pharmaceuticals.

[64]  Dejenie Shiferaw Teklu,et al.  Extended-spectrum beta-lactamase production and multi-drug resistance among Enterobacteriaceae isolated in Addis Ababa, Ethiopia , 2019, Antimicrobial Resistance & Infection Control.

[65]  A. Uhlemann,et al.  Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat , 2019, Front. Microbiol..

[66]  G. Węgrzyn,et al.  Characterization of Bacteriophage vB-EcoS-95, Isolated From Urban Sewage and Revealing Extremely Rapid Lytic Development , 2019, Front. Microbiol..

[67]  R. Blasco,et al.  Study of pH Changes in Media during Bacterial Growth of Several Environmental Strains , 2018, Proceedings.

[68]  Muhammad Imran,et al.  Isolation, characterization and efficacy of phage MJ2 against biofilm forming multi-drug resistant Enterobacter cloacae , 2018, Folia Microbiologica.

[69]  D. Isaacs,et al.  Enterobacter cloacae osteoarticular infection without risk factors: Case report and review of the literature , 2018, Journal of paediatrics and child health.

[70]  V. Aquili,et al.  Resistance of phages lytic to pathogenic Escherichia coli to sanitisers used by the food industry and in home settings , 2018 .

[71]  Wen J. Li,et al.  RefSeq: an update on prokaryotic genome annotation and curation , 2017, Nucleic Acids Res..

[72]  Elliot J. Lefkowitz,et al.  Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV) , 2017, Nucleic Acids Res..

[73]  E. Mylonakis,et al.  Urinary tract infections caused by ESBL‐producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta‐analysis , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[74]  T. Kessler,et al.  Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial , 2017, BMC Urology.

[75]  P. Hyman,et al.  More Is Better: Selecting for Broad Host Range Bacteriophages , 2016, Front. Microbiol..

[76]  S. Abedon Phage therapy dosing: The problem(s) with multiplicity of infection (MOI) , 2016, Bacteriophage.

[77]  Eric P. Nawrocki,et al.  NCBI prokaryotic genome annotation pipeline , 2016, Nucleic acids research.

[78]  Jing Yuan,et al.  Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes , 2016, Scientific Reports.

[79]  N. Indrawattana,et al.  Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens , 2016, BioMed research international.

[80]  R. Zbinden,et al.  Bacteriophages as Potential Treatment for Urinary Tract Infections , 2016, Front. Microbiol..

[81]  Dmitry Antipov,et al.  hybridSPAdes: an algorithm for hybrid assembly of short and long reads , 2016, Bioinform..

[82]  Nelson Durán,et al.  Silver nanoparticles: A new view on mechanistic aspects on antimicrobial activity. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[83]  J. Klumpp,et al.  Potential of phage cocktails in the inactivation of Enterobacter cloacae--An in vitro study in a buffer solution and in urine samples. , 2016, Virus research.

[84]  B. Bakhshi,et al.  Particular Distribution of Enterobacter cloacae Strains Isolated from Urinary Tract Infection within Clonal Complexes , 2016, Iranian biomedical journal.

[85]  S. Réhman,et al.  Isolation and characterization of lytic phages TSE1-3 against Enterobacter cloacae , 2016 .

[86]  Andrey D. Prjibelski,et al.  Assembling short reads from jumping libraries with large insert sizes , 2015, Bioinform..

[87]  Roshmi Thomas,et al.  Inhibitory effect of silver nanoparticle fabricated urinary catheter on colonization efficiency of Coagulase Negative Staphylococci. , 2015, Journal of photochemistry and photobiology. B, Biology.

[88]  N. Fierer,et al.  The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome , 2015, PloS one.

[89]  F. Şahin,et al.  Enterobacter Strains Might Promote Colon Cancer , 2015, Current Microbiology.

[90]  M. Osthoff,et al.  Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[91]  Xiaosheng Ma,et al.  Enterobacter cloacae infection after anterior cervical decompression and fusion: case study and literature review. , 2015, International journal of clinical and experimental medicine.

[92]  Torsten Seemann,et al.  Prokka: rapid prokaryotic genome annotation , 2014, Bioinform..

[93]  Alla Lapidus,et al.  ExSPAnder: a universal repeat resolver for DNA fragment assembly , 2014, Bioinform..

[94]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[95]  Andrea Pinna,et al.  Orione, a web-based framework for NGS analysis in microbiology , 2014, Bioinform..

[96]  I. Goic-Barisic,et al.  Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia. , 2014, Microbial drug resistance.

[97]  Kamaljit Singh,et al.  Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department , 2013, Emergency medicine international.

[98]  Dmitry Antipov,et al.  Assembling Genomes and Mini-metagenomes from Highly Chimeric Reads , 2013, RECOMB.

[99]  Sergey I. Nikolenko,et al.  SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing , 2012, J. Comput. Biol..

[100]  Shane S. Sturrock,et al.  Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..

[101]  H. Ackermann Bacteriophage electron microscopy. , 2012, Advances in virus research.

[102]  J. Ayala,et al.  Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. , 2011, The Journal of antimicrobial chemotherapy.

[103]  A. Górski,et al.  The influence of external factors on bacteriophages—review , 2011, Folia Microbiologica.

[104]  T. Dean,et al.  Enumeration of bacteriophage particles , 2011, Bacteriophage.

[105]  C. Prudêncio,et al.  Post‐surgical wound infections involving Enterobacteriaceae with reduced susceptibility to β‐lactams in two Portuguese hospitals , 2010, International wound journal.

[106]  N. Perna,et al.  progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement , 2010, PloS one.

[107]  A. Kropinski Measurement of the rate of attachment of bacteriophage to cells. , 2009, Methods in molecular biology.

[108]  E. Lingohr,et al.  Enumeration of bacteriophages by double agar overlay plaque assay. , 2009, Methods in molecular biology.

[109]  L. Rice Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. , 2008, The Journal of infectious diseases.

[110]  B. Gibbins,et al.  Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.

[111]  M. Kaufmann,et al.  An outbreak of wound infection in cardiac surgery patients caused by Enterobacter cloacae arising from cardioplegia ice. , 2006, Journal of Hospital Infection.

[112]  B. Cunha,et al.  Enterobacter cloacae graft infection/bacteremia in a hemodialysis patient. , 2000, American journal of infection control.

[113]  M. Dabrowski,et al.  Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases. , 1984, Archivum immunologiae et therapiae experimentalis.

[114]  P. R. Edwards,et al.  A Proposed Genus Enterobacter , 1960 .